Education
About Us
Working with TipRanks
Follow Us
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
ABVC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.40 - $4.00
Previous CloseN/A
Volume151.09K
Average Volume (3M)382.19K
Market Cap
$67.76M
Enterprise Value$244.55M
Total Cash (Recent Filing)$217.26K
Total Debt (Recent Filing)$2.17M
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Nov 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding16,981,592
10 Day Avg. Volume538,835
30 Day Avg. Volume382,194
Financial Highlights & Ratios
PEG Ratio1.68
Price to Book (P/B)-1.59K
Price to Sales (P/S)0.00
P/FCF Ratio-76.60
Enterprise Value/Market Cap3.61
Enterprise Value/Revenue146.95
Enterprise Value/Gross Profit743.47
Enterprise Value/Ebitda-12.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ABVC BioPharma News
PremiumCompany Announcements
ABVC BioPharma Shareholders Approve Key Proposals
PremiumCompany Announcements
ABVC BioPharma Reports Strong Financial Growth
PremiumCompany Announcements
ABVC BioPharma Delays Yearly Report Filing
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.73% Mutual Funds
0.07% Other Institutional Investors
98.54% Public Companies and
Individual Investors
ABVC FAQ
What was ABVC BioPharma, Inc.’s price range in the past 12 months?
ABVC BioPharma, Inc. lowest stock price was $0.40 and its highest was $4.00 in the past 12 months.
What is ABVC BioPharma, Inc.’s market cap?
ABVC BioPharma, Inc.’s market cap is $67.76M.
When is ABVC BioPharma, Inc.’s upcoming earnings report date?
ABVC BioPharma, Inc.’s upcoming earnings report date is Nov 17, 2025 which is in 131 days.
How were ABVC BioPharma, Inc.’s earnings last quarter?
ABVC BioPharma, Inc. released its earnings results on Mar 28, 2025. The company reported $0.016 earnings per share for the quarter, beating the consensus estimate of N/A by $0.016.
Is ABVC BioPharma, Inc. overvalued?
According to Wall Street analysts ABVC BioPharma, Inc.’s price is currently Overvalued.
Does ABVC BioPharma, Inc. pay dividends?
ABVC BioPharma, Inc. does not currently pay dividends.
What is ABVC BioPharma, Inc.’s EPS estimate?
ABVC BioPharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ABVC BioPharma, Inc. have?
ABVC BioPharma, Inc. has 16,981,592 shares outstanding.
What happened to ABVC BioPharma, Inc.’s price movement after its last earnings report?
ABVC BioPharma, Inc. reported an EPS of $0.016 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.5%.
Which hedge fund is a major shareholder of ABVC BioPharma, Inc.?
Currently, no hedge funds are holding shares in ABVC
ABVC BioPharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
439.18%
12-Months-Change
Fundamentals
Return on Equity
-27.00%
Trailing 12-Months
Asset Growth
1.29%
Trailing 12-Months
Company Description
ABVC BioPharma, Inc.
ABVC BioPharma, Inc. (ABVC) is a biopharmaceutical company engaged in the development of new drugs and medical devices. The company operates within the pharmaceutical and biotechnology sectors, focusing on innovative therapeutics for the treatment of central nervous system disorders, oncology, and other unmet medical needs. ABVC's core products include a portfolio of drug candidates and medical device technologies that are in various stages of clinical development.